Abstract
The neutralizing epitope (K-COE) of the spike protein from a Korean strain of porcine epidemic diarrhea virus (PEDV) has been shown to prevent and foster an immune response to PED, when orally adjusted. The cell surface of the budding yeast,Saccharomyces cerevisiae, was engineered to anchor the K-COE on the outer layer of the cell, and consequently, the altered yeast was applied as a dietary complement for animal feed, with immunogenic functions. In this study, the K-COE gene (K-COE) of the Korean strain of PEDV with the signal peptide of rice amylase 1A (Ramy 1A), was fused with the gene encoding the carboxyterminal half (320 amino acid residues from the C terminus) of yeast α-agglutinin, a mating associated protein that is anchored covalently to the cell wall. The glyceraldehyde-3-phosphate dehydrogenase (GPD) promoter was selected in order to direct the expression of the fusion construct, and the resulting recombinant plasmid was then introduced intoS. cerevisiae. The surface display of K-COE was visualized via confocal microscopy using a polyclonal antibody against K-COE as the primary antibody, and FITC (fluorescein isothiocyanate)-conjugated goat anti-mouse IgG as the secondary antibody. The display of the K-COE on the cell surface was further verified via Western blot analysis using the cell wall fraction after the administration of α-1,3-glucanase/PNGase F/β-mannosidase treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Egberink, H. F., J. Ederveen, P. Callebaut, and M. C. Horzinek (1988) Characterization of the structural proteins of porcine epizootic diarrhea virus, strain CV777.Am. J. Vet. Res. 49: 1320–1324.
Pensaert, M. B. and P. de Bouck (1978) A new coronavirus-like particle associated with diarrhea in swine.Arch. Virol. 58: 243–247.
Wood, E. N. (1977) An apparently new syndrome of porcine epidemic diarrhea.Vet. Rec. 100: 243–244.
Chae, C., O. Kim, C. Choi, K. Min, W. S. Cho, J. Kim, and J. H. Tai (2000) Prevalence of porcine epidemic diarrhea virus and transmissible gastroenteritis virus infection in Korean pigs.Vet. Rec. 147: 606–608.
Jimenez, G., J. M. Castro, M. del Pozzo, I. Correa, J. de la Torre, and L. Enjuanes (1986) Identification of a coronavirus inducing porcine gastroenteritis in Spain.Proc. Int. Pig Vet. Soc. Congr. 9: 186.
Pensaert, M. B. (1999) Procine epidemic diarrhea. pp. 179–185. In: B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. I. Taylor (eds.).Diseases of Swine. Iowa University Press, Iowa, USA.
Ducatelle, R., W. Coussement, M. Pensaert, P. de Bouck, and J. Hoorens (1981)In vivo morphogenesis of a new porcine enteric coronavirus, CV777.Arch Virol. 68: 35–44.
Knuchel, M., M. Ackermann, H. K. Muller, and U. Kihm (1992) An ELISA for detection of antibodies against porcine epidemic diarrhea virus (PEDV) based on the specific solubility of the viral surface glycoprotein.Vet. Microbiol. 32: 117–134.
Duarte, M. and H. Laude (1994) Sequence of the spike protein of the porcine epidemic diarrhoea virus.J. Gen. Virol. 75: 1195–1200.
Chang, S. H., J. L. Bae, T. J. Kang, J. Kim, G. H. Chung, C. W. Lim, H. Laude, M. S. Yang, and Y. S. Jang (2002) Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus.Mol. Cells 14: 295–299.
Kang, T. J., J. E. Seo, D. H. Kim, T. G. Kim, Y. S. Jang, and M. S. Yang (2005) Cloning and sequence analysis of the Korean strain of spike gene of porcine epidemic diarrhea virus and expression of its neutralizing epitope in plants.Protein Expr. Purif. 41: 378–383.
Bae, J. L., J. G. Lee, T. J. Kang, H. S. Jang, Y. S. Jang, and M. S. Yang (2003) Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen.Vaccine 21: 4052–4058.
Service, R. F. (1994) Triggering the first line of defense.Science 265: 1522–1524.
Walker, R. I. (1994) New strategies for using mucosal vaccination to achieve more effective immunization.Vaccine 12: 387–400.
McFarland, L. V. and P. Bernasconi (1993)Saccharomyces boulardii: a review of an innovative biotherapeutic agent.Microb. Ecol. Health Dis. 6: 157–171.
Corthier, G., F. Lucas, S. Jouvert, and F. Castex (1992) Effect of oralSaccharomyces boulardii treatment on the activity ofClostridium difficile toxins in mouse digestive tract.Toxicon 30: 1583–1589.
Berg, R., P. Bernasconi, D. Fowler, and M. Gautreaux (1993) Inhibition ofCandida albicans translocation from the gastrointestinal tract of mice by oral administration ofSaccharomyces boulardii.J. Infect. Dis. 168: 1314–1318.
Schellenberg, D., A. Bonington, C. M. Champion, R. Lancaster, S. Webb, and J. Main (1994) Treatment ofClostridium difficile diarrhoea with brewer's yeast.Lancet 343: 171–172.
Fattal-German, M. and B. Bizzini (1992) Assessment of the anti-viral effect of a short-term oral treatment of mice with liveSaccharomyces cerevisiae cells.Dev. Biol. Stand. 77: 115–120.
Colby, D. W., B. A. Kellogg, C. P. Graff, Y. A. Yeung, J. S. Swers, and K. D. Wittrup (2004) Engineering antibody affinity by yeast surface display.Methods Enzymol. 388: 348–358.
Kondo, A. and M. Ueda (2004) Yeast cell-surface display—applications of molecular display.Appl. Microbiol. Biotechnol. 64: 28–40.
Schreuder, M. P., C. Deen, W. J. A. Boersma, P. H. Pouwels, and F. M. Klis (1996) Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine.Vaccine 14: 383–388.
In, M. J., D. C. Kim, and H. J. Chae (2005) Downstream process for the production of yeast extract using brewer's yeast cells.Biotechnol. Bioprocess Eng. 10: 85–90.
Chen, L. J., Y. L. Xu, F. W. Bai, W. A. Anderson, and M. Moo-Young (2005) Observed quasi-steady kinetics of yeast cell growth and ethanol formation under very high gravity fermentation condition.Biotechnol. Bioprocess Eng. 10: 115–121.
Nagahisa K., T. Nakajima, K. Yoshikawa, T. Hirasawa, Y. Katakura, C. Furusawa, S. Shioya, and H. Shimizu (2005) DNA microarray analysis onSaccharomyces cerevisiae under high carbon dioxide concentration in fermentation process.Biotechnol. Bioprocess Eng. 10: 451–461.
Hwang, S. Y., C. H. Yoo, J. Y. Jeon, S. C. Choi, and E. K. Lee (2005) Quantitative assay of hepatitis B surface antigen by using surface plasmon resonance biosensor.Biotechnol. Bioprocess Eng. 10: 309–314.
Sambrook, J., E. F. Fritsch, and T. Maniatis (1989)Molecular Cloning: ALaboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
Shon, J. H., E. S. Choi, B. H. Chung, D. J. Youn, J. H. Seo, and S. K. Rhee (1995) Process development of the production of recombinant hirudin inSaccharomyces cerevisiae: from upstream to downstream.Process Biochem. 30: 653–660.
Kim, M. J., T. H. Kwon, Y. S. Jang, M. S. Yang, and D. H. Kim (2000) Expression of murine GM-CSF in recombinantAspergillus niger.J. Microbiol. Biotechnol 10: 287–292.
Park, E. H., Y. M. Shin, Y. Y. Lim, T. H. Kwon, D. H. Kim, and M. S. Yang (2000) Expression of glucose oxidase by using recombinant yeast.J. Biotechnol. 81: 35–44.
Park, S. M., A. Y. Mo, Y. S. Jang, J. H. Lee, M. S. Yang, and D. H. Kim (2004) Expression of a functional human tumor necrosis factor-α (hTNF-α) in, yeastSaccharomyces cerevisiae.Biotechnol. Bioprocess Eng. 9: 292–296.
Shin, Y. M., T. H. Kwon, K. S. Kim, K. S. Chae, D. H. Kim, J. H. Kim, and M. S. Yang (2001) Enhanced iron uptake ofSaccharomyces cerevisiae by heterologous expression of a tadpole ferritin gene.Appl. Environ. Microbiol. 67: 1280–1283.
Ge, L. and P. Rudolph (1997) Simultaneous introduction of multiple mutations using overlap extension PCR.Biotechniques 22: 28–30.
Lim, Y. Y., E. H. Park, J. H. Kim, S. M. Park, H. S. Jang, Y. J. Park, S. W. Yoon, M. S. Yang, and D. H. Kim (2001) Enhanced and targeted expression of fungal phytase inSaccharomyces cerevisiae.J. Microbiol. Biotechnol. 11: 915–921.
Mo, A. Y., S. M. Park, Y. S. Kim, M. S. Yang, and D. H. Kim (2005) Expression of fungal phytase on the cell surface ofSaccharomyces cerevisiae.Biotechnol. Bioprocess Eng. 10: 576–581.
Ito, H., Y. Fukuda, K. Murata, and A. Kimura (1983) Transformation of intact yeast cells treated with alkali cations.J. Bacteriol. 153: 163–168.
Pringle, J. R., R. A. Preston, A. E. Adams, T. Stearns, D. G. Drubin, B. K. Haarer, and E. W. Jones (1989) Fluorescence microscopy methods for yeast.Methods Cell Biol. 31: 357–435.
Loeper, J., B. Louérat-Oriou, C. Duport, and D. Pompon (1998) Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent.Mol. Pharmacol. 54: 8–13.
Murai, T., M. Ueda, M. Yamamura, H. Atomi, Y. Shibasaki, N. Kamasawa, M. Osumi, T. Amachi, and A. Tanaka (1997) Construction of a starch-utilizing yeast by cell surface engineering.Appl. Environ. Microbiol. 63: 1362–1366.
Huang, D. and E. V. Shusta (2005) Secretion and surface display of green fluorescent protein using the yeastSaccharomyces cerevisiae.Biotechnol. Prog. 21: 349–357.
Shibasaki, S., M. Ueda, T. Iizuka, M. Hirayama, Y. Ikeda, N. Kamasawa, M. Osumi, and A. Tanaka (2001) Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface ofSaccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses.Appl. Microbiol. Biotechnol. 55: 471–475.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, SM., Mo, AY., Lim, JG. et al. Surface displayed expression of a neutralizing epitope of spike protein from a Korean strain of porcine epidemic diarrhea virus. Biotechnol. Bioprocess Eng. 12, 690–695 (2007). https://doi.org/10.1007/BF02931087
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02931087